Targeting ACE2–RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity Assay

Mostrar otras versiones (1)

[Image: see text] The COVID-19 pandemic, caused by SARS-CoV-2, is a pressing public health emergency garnering a rapid response from scientists across the globe. Host cell invasion is initiated through direct binding of the viral spike protein to the host receptor angiotensin-converting enzyme 2 (AC...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanson, Quinlin M., Wilson, Kelli M., Shen, Min, Itkin, Zina, Eastman, Richard T., Shinn, Paul, Hall, Matthew D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688046/
https://www.ncbi.nlm.nih.gov/pubmed/33330843
http://dx.doi.org/10.1021/acsptsci.0c00161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688046/
https://www.ncbi.nlm.nih.gov/pubmed/33330843
http://dx.doi.org/10.1021/acsptsci.0c00161

Ejemplares similares